<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00792259</url>
  </required_header>
  <id_info>
    <org_study_id>Topcon 01</org_study_id>
    <nct_id>NCT00792259</nct_id>
  </id_info>
  <brief_title>Topcon 3D OCT-1000 Optical Coherence Tomography System</brief_title>
  <official_title>Topcon 3D OCT-1000 Optical Coherence Tomography System for Measurements of Retinal and RNFL Thicknesses: Precision and Agreement Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Topcon Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Topcon Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical protocol is to perform a comparison of Retinal and Retinal Nerve
      Fiber Layer (RNFL) thickness measurements between the Topcon 3D-1000 and the identified
      predicate device. In addition, this protocol performs a comparison of the thickness
      measurement results from images collected and analyzed with the Zeiss Stratus OCT to images
      collected with the Zeiss Stratus OCT and imported into the Topcon 3D OCT-1000 StratusViewer
      for analysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device</measure>
    <time_frame>30 Minutes</time_frame>
    <description>The precision and agreement measures the thickness of RNFL and Full Retinal Thickness of the study device and is compared to the predicate device to show agreement.
Keywords, ILM - Internal Limiting Membrane RPE - Retinal Pigment Epithelium RNFL - Retinal Nerve Fiber Layer</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Retinal Disease</condition>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with Retinal Disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients without Retinal Disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Normal Subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ophthalmology practice
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Retinal Disease Study

        No Retinal Disease:

        Inclusion Criteria:

          -  Male or female

          -  Between 18 and 80 years of age

          -  Either eye, but only one eye per subject will be enrolled

          -  Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.

        Exclusion Criteria:

          -  Any known ocular disease

          -  Any systemic disease that could result in ocular manifestations such as hypertension,
             diabetes, heart disease, etc.

          -  Topcon image quality factor ≤ 44 or Stratus signal strength &lt; 5.

        Retinal Disease

        Inclusion Criteria:

          -  Male or female

          -  Between 18 and 80 years of age

          -  Either eye, but only one eye per subject will be enrolled

          -  Symptoms consistent with one of the following retinal diseases: diabetic macular
             edema, cystoid macular edema, epiretinal membrane, macular hole, wet AMD and dry AMD
             for which OCT imaging is warranted. At lease one (1) case each of these diseases will
             be included in the study

          -  A range of retinal thickness will be included

          -  Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.

        Exclusion Criteria:

          -  Presence of glaucoma

          -  Topcon image quality factor ≤ 44 or Stratus signal strength &lt; 5.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Retina Consultations</name>
      <address>
        <city>Bronxville</city>
        <state>New York</state>
        <zip>10708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Eye and Ear-Glaucoma Associates of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vitreous-Retina-Macula Consultants of NY</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2008</study_first_submitted>
  <study_first_submitted_qc>November 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2008</study_first_posted>
  <results_first_submitted>December 12, 2013</results_first_submitted>
  <results_first_submitted_qc>June 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 17, 2015</results_first_posted>
  <last_update_submitted>June 15, 2015</last_update_submitted>
  <last_update_submitted_qc>June 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Retinal Disease Eyes</title>
          <description>Retinal Disease subjects with ocular pathology</description>
        </group>
        <group group_id="P2">
          <title>Normal Subjects</title>
          <description>Normal subjects with no known ocular pathology</description>
        </group>
        <group group_id="P3">
          <title>Glaucoma Subjects</title>
          <description>Subjects presented with Glaucoma</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Poor Quality Scans</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>20 Normal Subjects 15 Retinal Disease subjects 13 Glaucoma Subjects</population>
      <group_list>
        <group group_id="B1">
          <title>Normal Subjects</title>
          <description>Normal Subjects with no known ocular pathology</description>
        </group>
        <group group_id="B2">
          <title>Retinal Disease Subjects</title>
          <description>Retinal Disease subjects with ocular pathology</description>
        </group>
        <group group_id="B3">
          <title>Glaucoma Subjects</title>
          <description>Glaucoma subjects presented with pathology</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="13"/>
            <count group_id="B4" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.45" spread="10.36"/>
                    <measurement group_id="B2" value="66.6" spread="13.92"/>
                    <measurement group_id="B3" value="59.1" spread="17.63"/>
                    <measurement group_id="B4" value="50.52" spread="20.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device</title>
        <description>The precision and agreement measures the thickness of RNFL and Full Retinal Thickness of the study device and is compared to the predicate device to show agreement.
Keywords, ILM - Internal Limiting Membrane RPE - Retinal Pigment Epithelium RNFL - Retinal Nerve Fiber Layer</description>
        <time_frame>30 Minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Subjects</title>
            <description>Normal subjects with no known ocular pathology</description>
          </group>
          <group group_id="O2">
            <title>Retinal Disease Eyes</title>
            <description>Retinal Disease subjects with ocular pathology</description>
          </group>
          <group group_id="O3">
            <title>Glaucoma Subjects</title>
            <description>Subjects presented with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device</title>
          <description>The precision and agreement measures the thickness of RNFL and Full Retinal Thickness of the study device and is compared to the predicate device to show agreement.
Keywords, ILM - Internal Limiting Membrane RPE - Retinal Pigment Epithelium RNFL - Retinal Nerve Fiber Layer</description>
          <units>µm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Retinal Thickness ILM-IS/OS 3D OCT-1000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235.0" spread="9.03"/>
                    <measurement group_id="O2" value="236.1" spread="48.06"/>
                    <measurement group_id="O3" value="NA">Subject group not observed for this measurement</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retinal Thickness ILM-IS/OS Stratus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="236.0" spread="12.54"/>
                    <measurement group_id="O2" value="263.1" spread="48.66"/>
                    <measurement group_id="O3" value="NA">Subject group not observed for this measurement</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retinal Thickness ILM-RPE 3D OCT-1000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="252.8" spread="7.68"/>
                    <measurement group_id="O2" value="279.5" spread="45.36"/>
                    <measurement group_id="O3" value="NA">Subject group not observed for this measurement</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retinal Thickness ILM-BM 3D OCT-1000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="296.0" spread="8.97"/>
                    <measurement group_id="O2" value="318.5" spread="41.90"/>
                    <measurement group_id="O3" value="NA">Subject group not observed for this measurement</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RNFL Thickness 3D OCT-1000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.4" spread="10.50"/>
                    <measurement group_id="O2" value="NA">Subject group not observed for this measurement</measurement>
                    <measurement group_id="O3" value="70.7" spread="19.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RNFL Thickness Stratus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.9" spread="9.98"/>
                    <measurement group_id="O2" value="NA">Subject group not observed for this measurement</measurement>
                    <measurement group_id="O3" value="72.1" spread="20.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 hour</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Retinal Disease Eyes</title>
          <description>Retinal Disease subjects with ocular pathology</description>
        </group>
        <group group_id="E2">
          <title>Normal Subjects</title>
          <description>Normal subjects with no known ocular pathology</description>
        </group>
        <group group_id="E3">
          <title>Glaucoma Subjects</title>
          <description>Subjects presented with glaucoma</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bob Gibson</name_or_title>
      <organization>Topcon Medical Systems</organization>
      <phone>(201) 599-5121</phone>
      <email>RGIBSON@TOPCON.COM</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

